• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

类风湿关节炎患者与非破坏性慢性关节炎患者血清及滑液中sRANKL和OPG的比较

sRANKL and OPG in serum and synovial fluid of patients with rheumatoid arthritis in comparison to non-destructive chronic arthritis.

作者信息

Hein Gert E, Meister Marit, Oelzner Peter, Franke Sybille

机构信息

Department of Internal Medicine III, Section of Rheumatology and Osteology, Friedrich-Schiller University, Jena, Germany.

出版信息

Rheumatol Int. 2008 Jun;28(8):765-9. doi: 10.1007/s00296-007-0514-3. Epub 2008 Jan 3.

DOI:10.1007/s00296-007-0514-3
PMID:18172654
Abstract

The aim of this study was to investigate sRANKL and OPG levels in serum and synovial fluid (SF) and to evaluate their relations in patients with RA in comparison to those with non-erosive arthritis (NEA). The study included 45 unselected RA patients with knee joint effusions and 27 patients with knee joint effusions because of NEA. Serum and SF samples were investigated isochronously. OPG and sRANKL were measured by ELISA assays. In RA, sRANKL levels were higher in serum than in SF (P = 0.007). In contrast, the NEA revealed higher sRANKL in SF compared to the serum (P = 0.001). Though in RA the average levels of sRANKL(ser) were 5.6 times and of sRANKL(syn) 1.5 times higher than in NEA, the differences were not significant. The free (unbound) OPG in SF was not significantly different in RA compared to NEA. Also in serum, the measured free OPG was only slightly higher in RA. There were no significant differences between RA and NEA concerning ESR and CRP. Significant correlations could be found between sRANKL(syn )and CRP (r = 0.453; P = 0.005) as well as ESR (r = 0.362; P = 0.033) in RA. Nearly a positive correlation was evident also between sRANKL(syn) and CRP in NEA (r = 0.520; P = 0.08). RA and NEA differ in particular concerning their power and intensity to destruct the juxtaarticular bone. This is the most remarkable finding of this study, that in RA a high part of sRANKL seems to be OPG bound and cleared by the blood stream, but the sRANKL neutralizing capacity of produced OPG in opposite to NEA is not sufficient to prevent osteoclast activation and bone destruction in the RA joint.

摘要

本研究旨在调查血清和滑液(SF)中可溶性核因子κB受体活化因子配体(sRANKL)和骨保护素(OPG)水平,并评估类风湿关节炎(RA)患者与非侵蚀性关节炎(NEA)患者中它们之间的关系。该研究纳入了45例未经选择的有膝关节积液的RA患者和27例因NEA导致膝关节积液的患者。同步检测血清和SF样本。通过酶联免疫吸附测定(ELISA)法测量OPG和sRANKL。在RA中,血清中的sRANKL水平高于SF(P = 0.007)。相反,NEA患者的SF中的sRANKL水平高于血清(P = 0.001)。虽然在RA中,血清sRANKL平均水平比NEA高5.6倍,滑液sRANKL高1.5倍,但差异无统计学意义。与NEA相比,RA患者SF中游离(未结合)OPG无显著差异。血清中检测到的游离OPG在RA中也仅略高。RA和NEA在红细胞沉降率(ESR)和C反应蛋白(CRP)方面无显著差异。在RA中,sRANKL(滑液)与CRP(r = 0.453;P = 0.005)以及ESR(r = 0.362;P = 0.033)之间存在显著相关性。在NEA中,sRANKL(滑液)与CRP之间也几乎呈正相关(r = 0.520;P = 0.08)。RA和NEA在破坏关节周围骨骼的能力和强度方面存在差异。本研究最显著的发现是,在RA中,大部分sRANKL似乎与OPG结合并被血流清除,但与NEA相反,所产生的OPG的sRANKL中和能力不足以防止RA关节中的破骨细胞活化和骨破坏。

相似文献

1
sRANKL and OPG in serum and synovial fluid of patients with rheumatoid arthritis in comparison to non-destructive chronic arthritis.类风湿关节炎患者与非破坏性慢性关节炎患者血清及滑液中sRANKL和OPG的比较
Rheumatol Int. 2008 Jun;28(8):765-9. doi: 10.1007/s00296-007-0514-3. Epub 2008 Jan 3.
2
Osteoprotegerin and the receptor activator of NF-kappa B ligand in the serum and synovial fluid. A comparison of patients with longstanding rheumatoid arthritis and osteoarthritis.血清和滑液中的骨保护素及核因子κB受体活化因子配体。长期类风湿关节炎患者与骨关节炎患者的比较。
Rheumatol Int. 2005 Nov;26(1):63-9. doi: 10.1007/s00296-004-0579-1. Epub 2005 May 12.
3
Gingival crevicular fluid, serum levels of receptor activator of nuclear factor-κB ligand, osteoprotegerin, and interleukin-17 in patients with rheumatoid arthritis and osteoporosis and with periodontal disease.龈沟液、核因子-κB 配体受体激活剂、骨保护素和白细胞介素-17 在类风湿关节炎和骨质疏松症伴牙周病患者中的水平。
J Periodontol. 2013 Nov;84(11):1627-37. doi: 10.1902/jop.2013.120595. Epub 2013 Jan 17.
4
High levels of osteoprotegerin and soluble receptor activator of nuclear factor kappa B ligand in serum of rheumatoid arthritis patients and their normalization after anti-tumor necrosis factor alpha treatment.类风湿关节炎患者血清中骨保护素和核因子κB受体活化因子配体水平升高及其在抗肿瘤坏死因子α治疗后的正常化。
Arthritis Rheum. 2002 Jul;46(7):1744-53. doi: 10.1002/art.10388.
5
Assessment of Serum sRANKL, sRANKL/OPG Ratio, and Other Bone Turnover Markers with the Estimated 10-Year Risk of Major and Hip Osteoporotic Fractures in Rheumatoid Arthritis: A Cross-Sectional Study.评估类风湿关节炎患者血清 sRANKL、sRANKL/OPG 比值和其他骨转换标志物与 10 年主要和髋部骨质疏松性骨折风险的相关性:一项横断面研究。
Biomed Res Int. 2021 Aug 30;2021:5567666. doi: 10.1155/2021/5567666. eCollection 2021.
6
High levels of synovial fluid osteoprotegerin (OPG) and increased serum ratio of receptor activator of nuclear factor-kappa B ligand (RANKL) to OPG correlate with disease severity in patients with primary knee osteoarthritis.原发性膝骨关节炎患者滑液中骨保护素(OPG)水平升高以及血清中核因子κB受体活化因子配体(RANKL)与OPG的比值增加与疾病严重程度相关。
Clin Biochem. 2008 Jun;41(9):746-9. doi: 10.1016/j.clinbiochem.2008.02.011. Epub 2008 Mar 8.
7
Soluble receptor activator of NFkappa B-ligand and osteoprotegerin in rheumatoid arthritis - relationship with bone mineral density, disease activity and bone turnover.类风湿关节炎中可溶性核因子κB受体活化因子配体与骨保护素——与骨密度、疾病活动度及骨转换的关系
Clin Rheumatol. 2007 Dec;26(12):2127-2135. doi: 10.1007/s10067-007-0639-5. Epub 2007 May 31.
8
Synovial fluid RANKL and matrix metalloproteinase levels in enthesitis related arthritis subtype of juvenile idiopathic arthritis.幼年特发性关节炎的附着点炎相关关节炎亚型中的滑液核因子κB受体活化因子配体和基质金属蛋白酶水平
Rheumatol Int. 2009 Jun;29(8):907-11. doi: 10.1007/s00296-008-0805-3. Epub 2008 Dec 4.
9
The imbalance between osteoprotegerin and cathepsin K in the serum of patients with longstanding rheumatoid arthritis.长期类风湿性关节炎患者血清中骨保护素与组织蛋白酶K之间的失衡
Rheumatol Int. 2008 May;28(7):637-41. doi: 10.1007/s00296-007-0506-3. Epub 2007 Dec 13.
10
Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients.活化的人T细胞可直接诱导人单核细胞形成破骨细胞:T细胞在类风湿关节炎患者骨破坏中的可能作用。
Arthritis Rheum. 2001 May;44(5):1003-12. doi: 10.1002/1529-0131(200105)44:5<1003::AID-ANR179>3.0.CO;2-#.

引用本文的文献

1
Serum sclerostin in high-activity adult patients with juvenile idiopathic arthritis.青少年特发性关节炎高活动度成年患者的血清硬化蛋白
Arthritis Res Ther. 2014 Oct 4;16(5):460. doi: 10.1186/s13075-014-0460-x.
2
Role of RANKL-RANK/osteoprotegerin pathway in cardiovascular and bone disease associated with HIV infection.RANKL-RANK/骨保护素通路在与HIV感染相关的心血管和骨骼疾病中的作用。
AIDS Rev. 2014 Jul-Sep;16(3):123-33.
3
A significant association exists between receptor tyrosine kinase-like orphan receptor 2 gene variants and the OPG/RANKL ratio in human plasma.

本文引用的文献

1
Peripheral blood T lymphocytes from patients with early rheumatoid arthritis express RANKL and interleukin-15 on the cell surface and promote osteoclastogenesis in autologous monocytes.早期类风湿关节炎患者的外周血T淋巴细胞在细胞表面表达核因子κB受体活化因子配体(RANKL)和白细胞介素-15,并促进自体单核细胞的破骨细胞生成。
Arthritis Rheum. 2006 Apr;54(4):1151-64. doi: 10.1002/art.21731.
2
RANKL protein is expressed at the pannus-bone interface at sites of articular bone erosion in rheumatoid arthritis.RANKL蛋白在类风湿关节炎关节骨侵蚀部位的血管翳-骨界面表达。
Rheumatology (Oxford). 2006 Sep;45(9):1068-76. doi: 10.1093/rheumatology/kel045. Epub 2006 Feb 20.
3
受体酪氨酸激酶样孤儿受体 2 基因变异与人血浆中 OPG/RANKL 比值存在显著相关性。
Osteoporos Int. 2012 Jul;23(7):1899-907. doi: 10.1007/s00198-011-1820-x. Epub 2011 Nov 5.
4
Dickkopf-1 as potential biomarker to evaluate bone erosion in systemic lupus erythematosus.Dickkopf-1 作为评估系统性红斑狼疮骨侵蚀的潜在生物标志物。
J Clin Immunol. 2010 Sep;30(5):669-75. doi: 10.1007/s10875-010-9436-z. Epub 2010 Jun 30.
5
A functional RANKL polymorphism associated with younger age at onset of rheumatoid arthritis.一种与类风湿关节炎发病年龄较轻相关的功能性核因子κB受体活化因子配体(RANKL)基因多态性。
Arthritis Rheum. 2010 Oct;62(10):2864-75. doi: 10.1002/art.27589.
6
Synovial tissue rank ligand expression and radiographic progression in rheumatoid arthritis: observations from a proof-of-concept randomized clinical trial of cytokine blockade.滑膜组织等级配体表达与类风湿关节炎的放射学进展:细胞因子阻断的概念验证随机临床试验观察。
Rheumatol Int. 2010 Nov;30(12):1571-80. doi: 10.1007/s00296-009-1191-1. Epub 2009 Oct 22.
Osteoprotegerin and the receptor activator of NF-kappa B ligand in the serum and synovial fluid. A comparison of patients with longstanding rheumatoid arthritis and osteoarthritis.
血清和滑液中的骨保护素及核因子κB受体活化因子配体。长期类风湿关节炎患者与骨关节炎患者的比较。
Rheumatol Int. 2005 Nov;26(1):63-9. doi: 10.1007/s00296-004-0579-1. Epub 2005 May 12.
4
Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases.骨保护素/RANKL/RANK系统对骨骼和血管疾病的临床意义。
JAMA. 2004 Jul 28;292(4):490-5. doi: 10.1001/jama.292.4.490.
5
Osteoprotegerin expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathies and osteoarthritis and normal controls.类风湿关节炎、脊柱关节病、骨关节炎患者及正常对照者滑膜组织中骨保护素的表达。
Rheumatology (Oxford). 2003 Jan;42(1):123-34. doi: 10.1093/rheumatology/keg047.
6
Receptor activator NF-kappaB ligand (RANKL) expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathy, osteoarthritis, and from normal patients: semiquantitative and quantitative analysis.类风湿关节炎、脊柱关节病、骨关节炎患者及正常患者滑膜组织中核因子κB受体活化因子配体(RANKL)的表达:半定量和定量分析
Ann Rheum Dis. 2002 Dec;61(12):1047-54. doi: 10.1136/ard.61.12.1047.
7
High levels of osteoprotegerin and soluble receptor activator of nuclear factor kappa B ligand in serum of rheumatoid arthritis patients and their normalization after anti-tumor necrosis factor alpha treatment.类风湿关节炎患者血清中骨保护素和核因子κB受体活化因子配体水平升高及其在抗肿瘤坏死因子α治疗后的正常化。
Arthritis Rheum. 2002 Jul;46(7):1744-53. doi: 10.1002/art.10388.
8
Role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in bone cell biology.核因子-κB 受体激活剂配体和骨保护素在骨细胞生物学中的作用。
J Mol Med (Berl). 2001 Jun;79(5-6):243-53. doi: 10.1007/s001090100226.
9
Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients.活化的人T细胞可直接诱导人单核细胞形成破骨细胞:T细胞在类风湿关节炎患者骨破坏中的可能作用。
Arthritis Rheum. 2001 May;44(5):1003-12. doi: 10.1002/1529-0131(200105)44:5<1003::AID-ANR179>3.0.CO;2-#.
10
The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development.破骨细胞分化因子骨保护素配体对乳腺发育至关重要。
Cell. 2000 Sep 29;103(1):41-50. doi: 10.1016/s0092-8674(00)00103-3.